Luvometinib in Combination With Serplulimab for NF2-Related Tumors
Conditions : NF2-related Schwannomatosis; NF2; Neurofibromatosis Type 2; Vestibular Schwannoma; Meningioma Interventions : Drug: Luvometinib; Drug: Serplulimab Sponsors : Beijing Tiantan Hospital Not…
Read the full article2d agoen
Comments
Sign in to join the conversation.
No comments yet. Be the first.